Heidi H. van Ojik
- Radiology, Nuclear Medicine and Imaging top 5%
- Immunology top 10%
- Oncology top 10%
- Molecular Biology
- Immunology and Allergy top 10%
- Co-authors
- Jan G. J. van de WinkelAnnemiek B. van SprielWim H.J. KruitG. StoterJ.W. GratamaJohanneke E.A. PortieljeThomas ValeriusGeorge J. Weiner
- Topics
- Monoclonal and Polyclonal Antibodies Research (7 papers)HER2/EGFR in Cancer Research (4 papers)Glycosylation and Glycoproteins Research (3 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Heidi H. van Ojik
11 papers receiving 598 citations
Peers
Comparison fields: 5 of 66
- Radiology, Nuclear Medicine and Imaging 325
- Immunology 322
- Oncology 263
- Molecular Biology 245
- Immunology and Allergy 45
Countries citing papers authored by Heidi H. van Ojik
This map shows the geographic impact of Heidi H. van Ojik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi H. van Ojik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi H. van Ojik more than expected).
Fields of papers citing papers by Heidi H. van Ojik
This network shows the impact of papers produced by Heidi H. van Ojik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi H. van Ojik. The network helps show where Heidi H. van Ojik may publish in the future.
Co-authorship network of co-authors of Heidi H. van Ojik
This figure shows the co-authorship network connecting the top 25 collaborators of Heidi H. van Ojik. A scholar is included among the top collaborators of Heidi H. van Ojik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi H. van Ojik. Heidi H. van Ojik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 8 | |
| 3 | 13 | |
| 4 | 123 | |
| 5 | 62 | |
| 6 | 87 | |
| 7 | CpG-A and B oligodeoxynucleotides enhance the efficacy of antibody therapy by activating different effector cell populations. | 82 |
| 8 | 58 | |
| 9 | 106 | |
| 10 | 30 | |
| 11 | 43 |
About Heidi H. van Ojik
Heidi H. van Ojik is a scholar working on Complementary and Manual Therapy, Biological Psychiatry and Immunology and Allergy, having authored 11 papers that have together received 620 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Immunology (322 citations), Radiology, Nuclear Medicine and Imaging (325 citations) and Oncology (263 citations). Heidi H. van Ojik has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Jan G. J. van de Winkel, Annemiek B. van Spriel, Wim H.J. Kruit, G. Stoter, J.W. Gratama, Johanneke E.A. Portielje, Thomas Valerius, George J. Weiner, Wim K. Bleeker and Mischa Houtkamp. Their work appears in journals such as Blood, The Journal of Immunology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.